Paul B. Manning, 10% Owner at Taysha Gene Therapies, Inc. (TSHA), bought 2,666,666 shares at $2.25 ($6.0M) on 2024-06-27, disclosed to the SEC on 2024-07-01.
Open-market purchase of $6.0M TSHA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.25 | 1,333,333 | $3.0M | 50.0% |
| 2 | $2.25 | 1,333,333 | $3.0M | 50.0% |
| Total | $2.25 avg | 2,666,666 | $6.0M | 100% |
| Filing → |
| VRCA | BUY | 2025-11-25 | $35.0M | — | Filing → |
| LQDA | SELL | 2025-09-02 | $37.9M | — | Filing → |
| TSHA | BUY | 2025-06-03 | $2.1M | — | Filing → |